Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States. The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
P/E ratio for Sintx Technologies, Inc. (SINT)
P/E ratio as of 2023: -3.55
According to Sintx Technologies, Inc.'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -3.55. At the end of 2022 the company had a P/E ratio of -35.41.
P/E ratio history for Sintx Technologies, Inc. from 2011 to 2023
PE ratio at the end of each year
| Year | P/E ratio |
|---|---|
| 2023 | -3.55 |
| 2022 | -35.41 |
| 2021 | -269.74 |
| 2020 | -704.45 |
| 2019 | -95.62 |
| 2018 | -45.51 |
| 2017 | -208.83 |
| 2016 | -140.69 |
| 2015 | -124.38 |
| 2014 | -127.29 |
| 2013 | -1545.58 |
| 2012 | -365.54 |
| 2011 | -539.20 |